+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeNewslettersNextShare
 

We just got our first look at how Moderna's experimental coronavirus vaccine works in older adults

Aug 26, 2020, 20:59 IST
Business Insider
Nurse Kath Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y. an injection as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway Monday, July 27, 2020, in Binghamton, N.Y.AP Photo/Hans Pennink
  • Moderna on Wednesday shared more results from its early-stage coronavirus vaccine trial looking at how its vaccine works in older adults.
  • The shot was found to be safe and it created an immune response in trial participants who were older than 55.
  • Moderna is in the middle of running a 30,000 person trial that will determine whether the vaccine can prevent infection or disease.
Advertisement

We just got our best look yet at how Moderna's coronavirus vaccine might work in older adults.

The shot was found to be safe and it created an immune response in participants older than 55, according to data that Moderna presented on Wednesday. It hasn't yet been published in a peer-reviewed scientific journal.

The data is important because elderly Americans are more at risk from the novel coronavirus. Some vaccines don't work as well in older people.

The data builds on earlier results from the company that found that the vaccine created encouraging immune responses in healthy, younger volunteers. To be sure, more data is needed to determine whether the vaccine prevents coronavirus infections.

The interim data from the trial was presented Wednesday to the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

Advertisement

Read more: Moderna's CEO shared a detailed timeline for when we'll know if its coronavirus vaccine works, and cautions that you might not get a shot until the spring

Moderna is currently running a late-stage trial, testing 30,000 people to see whether its vaccine can prevent infection or disease. Moderna CEO Stephane Bancel told Business Insider that in a best-case scenario, we might know if the vaccine works by October.

Next Article